JamesJStarkMD

Oncology • Palm Beach, FL

Hematologic Oncology

Physician

Join to view full profile

Dr. Stark is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stark's full profile

Already have an account?

Office
2275 S. Ocean Blvd.
Apt. A-102
Palm Beach, FL 33480
Phone+1 757-676-6354

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1975 - 1977
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1972 - 1973
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1971 - 1972
Harvard Medical SchoolClass of 1971
Yale UniversityBA, cum laude, 1967

Certifications & Licensure

VA State Medical License 1977 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Ministering Spirit Bon Secours Health System, 2003
Fellow (FACP) American College of Physicians, 1999

Publications & Presentations

PubMed

7 citations
Alcaligenes xylosoxidans osteomyelitis without trauma in a patient with Good's syndrome.
James J. Stark
European Journal of Internal Medicine. 2007-09-01
31 citations
Spontaneous splenic rupture secondary to pegfilgrastim to prevent neutropenia in a patient with non-small-cell lung carcinoma.
Nicole J. Watring, Thomas W. Wagner, James J. Stark
The American Journal of Emergency Medicine. 2007-02-01
Electronic health records: who pays?
James J. Stark
Annals of Internal Medicine. 2006-12-05

Journal Articles

Neurally Mediated and Direct Effects of Acetylstrophanthidin on Canine Skeletal Muscle Vascular Resistance.
Stark, JJ, CA Sanders and WJ Powell, Jr, Circulation Research 30: 274-282
Improvement in Myocardial Function and Coronary Blood Flow in Ischemic Myocardium After Mannitol.
Willerson, JT, WJ Powell, Jr., TE Guiney, JJ Stark, CA Sanders and A Leaf, Journal of Clinical Investigation 51: 2989-2998
Clinical Investigations of the Nephrotoxicity of Cis-platinum (II) DichlorodiammineClinical Investigations of the Nephrotoxicity of Cis-platinum (II) Dichlorodiammine.
Stark, JJ and SB Howell, Clinical Pharmacology and Therapeutics 23: 461-466
Sequential Combination Chemotherapy and Surgery for Disseminated Testicular Cancer
Garnick, MB, GP Canellos, JP Richie and JJ Stark, Cancer Treatment Reports 63:1681-1686
Estrogen Receptor Activity and Hormonal Responsiveness in a Patient with Hodgkin's Disease.
Stark, JJ, JW Lloyd and PF Schellhammer, Ann Int Med 95: 186-187
Cis Diamminodichloro Platinum (II) Therapy for Advanced Ovarian Cancer.
Pesando, JM, SE Come, JJ Stark, LM Parker, CT Griffiths, and GP Canellos, Cancer Treatment Reports 64: 1147-1148
Continuous Infusion of Interleukin-2 and Cyclophosphamide as Treatment of Advanced Cancers: A National Biotherapy Study Group Trial.
Oldham, RK, J Stark, NM Barth, B Hoogstraten, CH Brown, T O'Connor, S Dupere and R. Birch, Molecular Biotherapy 3: 74-78
Sequencing of Chemotherapy and Radiotherapy in Breast Cancer.
Stark JJ, New England Journal of Medicine 335:1240
Interferon-alpha and Chemohormonal Therapy for Patients with Advanced Melanoma: Final Results of a Phase I-II Study of the Cancer Biotherapy Research Group and the Mi...
Stark JJ, R Dillman, R Schulof, M Wiemann, N Barth, P Honeycutt and G Soori, Cancer 82 (9): 1677-81
Continuous Infusion Floxuridine and Alpha Interferon in Metastatic Renal Cancer: A National Biotherapy Study Group Phase II Study.
Soori, GS, RS Schulof, JJ Stark, MC Wiemann, PJ Honeycutt, CK Church and CB DePriest, Cancer Investigation, 17 (6): 379-384
The Breasts of “Night”: Michelangelo as Oncologist.
Stark, JJ and JK Nelson, New England Journal of Medicine, 343 (21): 1577-8
Micronutrient Supplementation for Patients with Metastatic Cancer.
Stark, JJ, T Birdsall, G Anderson, D Nixon E Zang and G Haase, Nutrition and Cancer 38 (2): 296-298
Join now to see all

Books/Book Chapters

Epilogue to Eastern Virginia Cancer Statistics Review: 1985-1989.
Stark, JJEditors: Rosenthal.Tidewater Regional Cancer Network
Breast: Comprehensive Management of Benign and Malignant Disorders.
Chapter: Frontispiece text for Bland and Copeland
Stark, JJElsevier Publishers, Philadelphia, PAEdition 4,

Abstracts/Posters

The Breasts of Night: Michelangelo as Oncologist?
Nelson, JK and JJ Stark, Italian Renaissance section of annual meeting of College Art Association, Chicago, IL
Prevention of Cis-platinum Nephrotoxicity.
Stark, JJ SB Howell and J Carmody, Clinical Research.25: 412A
The Value of Surgical Restaging in Advanced Testicular Cancer.
Stark JJ, MB Garnick and GP Canellos, Virginia Medical Monthly
Treatment of advanced cancers with cytoxan (CTX) and interleukin-2 (rIL-2): a phase II study.
Oldham, RK, J Stark, N Barth, B Hoogstraten, CH Brown, S Dupere, R. Birch, Proc Am Assoc Cancer Research 31:268
Alpha Interferon and Chemo-Hormonal Therapy in Advanced Melanoma: A Phase I-II National Biotherapy Study Group/Mid-Atlantic Oncology Program Study.
Stark, JJ RS Schulof and M Wiemann, sixth annual meeting of Society for Biological Therapy, November 16-19, 1991, p. 20 of abstract book
Alpha Interferon and Chemo- Hormonal Therapy in Advanced Melanoma: Update of A Phase I-II NBSG/MAOP Study.
Stark, JJ, R Schulof, M Wiemann, N Barth and P Honeycutt, Journal of Immunotherapy 13 (1): 72-73
Alpha Interferon and Chemo-Hormonal Therapy in Advanced Melanoma: A Phase I-II NBSG/MAOP Study.
Stark JJ, R Schulof, M Wiemann, N Barth, P Honeycutt and G Soori, Proc Am Soc Clin Onc 12 (3):392
Phase II Trial of Continuous Infusion (CI) Floxuridine (FUDR) and interferon-Alpha-2b (a-IFN-2b) in Advanced Renal Cancer -- An NBSG Study.
Soori G, R Schulof, J. Stark, M. Wiemann, P. Honeycutt, J. Arnold and C. Church, Proc Am Soc Clin Onc 12 (3):236
Malignant Epidural Spinal Cord Compression in Breast Cancer.
Hankenson R, H Nevinny, A Hankenson, F Brunk, J Stark, D Miller, and RM Williams, Proc Am Soc Clin Onc 12 (3):86
Continuous Infusion Floxuridine and Interferon-Alpha 2b in Advanced Renal Cancer -- An NBSG Phase II Study.
Soori G, R Schulof, J Stark, M Wiemann, R Langdon and M Block, Eighth annual meeting of the Society for Biological Therapy, Nashville, TN
Combined Intra-arterial and Intravenous Chemotherapy for Locally Advanced Carcinoma of the Pancreas.
Stark J, J Frank, J Granick, D Miller, R Levin, P Sirijintakarn, D Wong, R Sanchez, A Mellijor and RM Williams, Proc Am Soc Clin Onc 13 (3):226
Alpha Interferon and Chemo-Hormonal Therapy in Advanced Melanoma: Final Results of a Phase I-II Study.
Stark JJ, R Schulof, M Wiemann, N Barth, P Honeycutt and G Soori, Sixteenth Annual Seminar of Cancer Researchers in Virginia, Norfolk, VA
Phase I/II Trial of the Safety and Efficacy of Shark Cartilage (Cartilade) in the Treatment of Advanced Cancers.
Miller DR, JL Granick, JJ Stark, GT Anderson, Proc Am Soc Clin Onc 16:49a
Outpatient Phase II Trial of Alpha Interferon, Subcutaneous Interleukin-2, 5-Fluorouracil, and Cis-Retinoic Acid in Patients with Metastatic Renal Cell Cancer.
Soori G, JJ Stark, MC Wiemann, PJ Honeycutt, BE Cogburn, DF Tai, C DePriest, LA Potts, C Church, R Schulof, and RO Dillman, Proc Am Soc Clin Onc 16:344a
Outpatient Phase II Trial of Alpha Interferon, Subcutaneous Interleukin-2, 5-Fluorouracil and Cis-Retinoic Acid in Patients with Metastatic Renal Cell Cancer.
Soori G, JJ Stark, M Wiemann, P Honeycutt, D Tai, T Dobbs, R. Langdon, B Cogburn, M Block, P Townley, R Dillman, C Church, and C DePriest, Proc Am Soc Clin Onc 18: 352a
Spontaneous splenic rupture after pegfilgrastim administration.
Watring, NJ, JJ Stark, and TW Wagner, Eastern Virginia Medical School 18th Annual Research Day
Join now to see all

Lectures

Advances In Medical Oncology.
Sentara Norfolk General Hospital, De Paul Hospital and Maryview Medical Center
Advances In Hematology And Oncology.
Sentara Norfolk General Hospital, De Paul Hospital and Maryview Medical Center
Skin Cancer.
EVMS and Chesapeake General Hospital
BIotherapy.
Sentara Norfolk General Hospital
Internal Medicine: Breast Cancer.
Sentara Norfolk General Hospital, De Paul Hospital and Maryview Medical Center
Immediate Breast Reconstruction.
EVGSM and Department of Plastic Surgery
Internal Medicine: Cancer detection
Sentara Norfolk General Hospital, De Paul Hospital and Maryview Medical Center
Cancer Detection And Treatment.
EVGSM and University of Florida School of Medicine
Breast Cancer.
Multiple Locations, 1990, 1991, 2005
Advances In Biotherapy in Oncology nursing.
Midwestern Regional Medical Center
Cancer detection.
Midwestern Regional Medical Center
Adjuvant Chemotherapy.
Chicago Medical School, North Chicago, IL
Nutritional Support Of The Cancer Patient.
Oncology Nursing Society of Southeastern Virginia
Chemotherapy of Neuroendocrine Tumors.
EVMS Diabetes Institutes, Norfolk, VA
Malignant Melanoma.
Finch University of the Health Sciences, North Chicago, IL
Clinical Pathways in Oncology Management.
Phoenix, AZ
Cancer and the Kidney.
Maryview Medical Center, Portsmouth, VA
Holistic Healing and Alternative Medicine: Fact vs. Fiction.
Charleston, SC
Cancer Detection and Cancer Prevention Pros and Cons of Alternative Medicine.
Friends Biannual Retreat, Virginia Beach, VA
Evidence-based Alternative and Complementary Medicine.
Integrative Medicine and Internal Medicine Clubs, EVMS
Post-transplant Lymphoproliferative Disease.
Maryview Medical Center
Through a Glass Darkly: A Revisionist Look at Endocrine Tumors.
Maryview Medical Center
New Approaches to the Treatment of Acute Myeloblastic Leukemia.
Maryview Medical Center
The Role of Complementary and Alternative Medicine in the Prevention and Treatment of Cancer.
Multiple Locations, 2001
Cancer and Nutrition: Holistic Healing for the New Millenium.
Chesapeake General Hospital
Join now to see all